BioPharm International Webcasts

 

LIVE WEBCASTS

More to come in 2015!

 


ON-DEMAND WEBCASTS

Implications of Cell Culture Conditions on Biologic Product Quality

Available until March 11, 2016

Understand factors that affect cell line quality from process development through production, including regulatory considerations, factors for optimized bioreactor performance, and glycan analysis methods.

Register free: www.biopharminternational.com/efficacy

Sponsored by SGS Life Science Services


Development Strategies for High-performing Perfusion Media

Available until March 24, 2016

Integrated continuous processing, comprising production in a high-cell density perfusion culture coupled to a continuous capture step, has been suggested as a universal biomanufacturing platform.Learn about a structured approach to develop a perfusion medium from commercially available medium and feeds, which resulted in a final process with a cell-specific perfusion rate that was a 75% decrease compared with the starting process conditions.

Register free: www.biopharminternational.com/bp/perfusion

Sponsored by GE Healthcare

 

 


The Future of Continuous Downstream Processing
Available until December 3, 2015

Where  is continuous downstream processing heading?  Join the discussion with Biogen Idec and GE Healthcare Life Science.

Register free: www.biopharminternational.com/continuousbioprocessing

Sponsored by GE Healthcare


Developing a Comprehensive Tool Kit for Microbial Identification
Available until Nov. 18, 2015
Learn about the application of various microbial identification methods, strain-typing techniques, microbial classifications, and the benefits of a comprehensive reference database. Attend this in depth presentation by Chris Gilmer, Sr. Microbiologist with Eurofins Lancaster Laboratories and Arnaud Carlotti, President, Eurofins IDmyk.

Register free www.pharmtech.com/Identification
Sponsored by Eurofins Lancaster Laboratories


New Innovations in UHPLC and LCMS Workflows for the Comprehensive Characterization of Monoclonal Antibodies [mAbs] and Antibody Drug Conjugates [ADCs]
Available until Nov. 13, 2015
Would you like to reduce method development time for mAb and ADC characterization from weeks to minutes and establish finalized methods that are more robust than previous methods? This webinar will describe new innovations and workflows for mAb characterization with advice on simplified method development and sample preparation.

Register free www.biopharminternational.com/Innovations
Sponsored by Thermo Fisher Scientific


Adding Mass Detection to Routine Peptide-Level Biotherapeutic Analysis
Available until Nov. 11, 2015
When peptide mass information is obtained from a simple mass detector, rather than a mass spectrometer used in full protein characterization, mass data becomes more easy and affordable to include as part of routine LC studies. This enables an analyst to rapidly confirm the expected mass of a synthetic peptide, track individual peptides during peptide mapping method development, build simple quantitative assays for measuring the extent of peptide modification, and rapidly troubleshoot unexpected LC/UV results by confirming peptide identity and the absence of coeluting species in a UV peak. In this webinar, we will review the useful insights available for peptide data that has been generated using Waters Empower 3 Software with an ACQUITY UPLC H-Class System configured with a TUV optical detector and the ACQUITY QDa Mass Detector.

Register free www.biopharminternational.com/detection
Sponsored by Waters


The Benefits of High Performing Chromatography Resins; Including POROS® XQ, A New Strong Anion Exchange
Available until October 29, 2015
Learn how high capacity, high resolution and salt tolerant ion-exchange (IEX) resins can help revolutionize your approach to bioprocess chromatography. An expert will demonstrate the benefits of the newest AEX resin to downstream purification processes, including increased process flexibility and productivity, and improved cost of goods.

Register free at www.pharmtech.com/POROSXQ
Sponsored by Life Tech


Preparing for the New Elemental Impurities Guidelines
Available until October 14, 2015
With the long anticipated revised guidelines for elemental impurities on the horizon, bio/pharmaceutical companies should initiate plans to transition to these new guidelines. In this webcast, experts (API, excipients and analytical testing) will discuss risk assessment, proposed test methods, and sample preparation techniques.

Register free at www.pharmtech.com/elemental
Sponsored by SGS Life Science Services


Chromatographic Removal of Aggregates in Downstream Purification of Monoclonal
Available until October 8, 2015
The past 15 to 20 years have seen advances in biotechnology that have propelled monoclonal antibodies (mAbs) as the top-selling class of therapeutic drugs. With the increased commercial utilization of these molecules, it is imperative that chromatographers have access to the tools necessary to develop purification processes that deliver safe, pure, and effective drug products. Aggregate removal is one of the most important aspects in mAb purification. Removing aggregates, especially soluble ones, is highly challenging because of their close physical and/or chemical similarity to the target of interest.

Register free at www.biopharminternational.com/Antibodies
Sponsored by TOSOH BIOSCIENCE


Analytical Separation of Antibody Drug Conjugates (ADCs) and Monoclonal Antibodies (mAbs) Various Chromatographic Modes?
Available until September 30, 2015
Antibody Drug Conjugates (ADCs) are more complex and heterogeneous than their corresponding unconjugated base antibody. Different chromatographic modes can be selected for analytical scale purification, based on the specificityof the individual ADC, the nature of the linker, the attachment sites, and more. With the advancement of HPLC analytical column chromatography, the separation of complex peptide mixtures derived from protease digestions of monoclonal antibodies (mAbs) and ADCs are possible.

Register free at www.biopharminternational.com/ADCs
Sponsored by TOSOH BIOSCIENCE


Fundamentals of Design of Experiments (DoE) in Protein Production and Purification
Available until September 30, 2015
Whether it is for bioprocessing applications or research labs, developing and optimizing your protein production and purification process requires a lot of experiments. As the number of experiments increases, so does the cost.

Register free at www.biopharminternational.com/DoE
Sponsored by GE Healthcare


Utilizing PepFinder Software for Interrogation of LC-MS Peptide Map Data of Biotherapeutics?
Available until September 17, 2015
The availability of commercial LC?MS software tools for full characterization of biotherapeutics has lagged behind the technological advances of MS instrumentation. Significant effort has been put into software tools to identify large mixtures of proteins in proteomics-based research. However, commercial software that focuses specifically on deep characterization of a single protein has been lacking. While proteomics software tools can be used to identify biotherapeutics, the majority of these tools do not have the ability to look for multiple and unexpected modifications, which are an important part of characterizing biotherapeutic drug products.

Register free at www.biopharminternational.com/Utilizing
Sponsored by Thermo Fisher Scientific


Accelerating Vaccine Development: Regulatory, Biosafety, and Clinical Strategies
Available until September 9, 2015
The drive to bring efficacious, more cost-effective vaccines to market is challenging vaccine makers to innovate throughout the development continuum. This webcast will provide companies developing seasonal and pandemic influenza vaccines, as well as universal vaccines, with vital regulatory, biosafety, and clinical testing strategies to accelerate development.

Register free at www.biopharminternational.com/vaccinedev
Sponsored by SGS Life Science Services


Glycan Profiling and Differential Analysis to Elucidate Functional Differences in Therapeutic Antibodies
Available until July 31, 2015
In this free webcast, experts from Agilent and Gilead Science will discuss the challenges of characterization of glycan profiles throughout various phases of therapeutic mAbs development. Audience members will learn about rapid glycopeptide and glycan analysis of monoclonal antibodies using LC, LC/MS and HILIC, and a microfluidic-based HPLC-Chip coupled to an Agilent Accurate-Mass Q-TOF LC/MS. The discussion will include differential analysis using MassHunter Molecular Feature Extractor and other software tools to elucidate functional differences in the studied antibodies.

Register free at www.biopharminternational.com/analysis
Sponsored by Agilent Technologies


Fast, Robust LC and LCMS Workflows for the Comprehensive Characterization of Bio-Therapeutic Proteins
Available until June 3, 2015
Would you like to reduce method development time for mAb characterization from weeks to minutes? Have finalized methods that are more robust than previous methods? The webinar will describe new technology and workflows for mAb characterization with advice on simplified method development.

Register free at www.biopharminternational.com/fast
Sponsored by Thermo Fisher Scientific


Delivering Biologics with a Difference
Available until June 5, 2015
As the biologics market continues to grow with additional launches, expanding indications, and approvals of biosimilars, the delivery platform will play a more critical role in product differentiation. Join us for this webinar to explore the advantages, challenges, case studies and science behind delivering biologics with a difference.

Register free at www.pharmtech.com/difference
Sponsored by Baxter BioPharma Solutions


MAb manufacturing:  where are we headed, cost or capabilities?
Available until May 27, 2015
MAb manufacturing,  where are we heading?  Join the discussion with Gunter Jagschies of GE Healthcare Life Sciences.

Register free at www.biopharminternational.com/MAb
Sponsored by GE Healthcare


Effective Viral Contamination Testing Programs for Biologics Product Manufacturing
Available until May 20, 2015
Biopharmaceutical manufacturers need comprehensive virus testing programs to ensure product safety throughout various manufacturing stages. Learn how to establish or improve practices for effective virus testing programs and review test methods for virus detection and quantitation throughout the biopharmaceutical manufacturing process.

Register free at www.biopharminternational.com/virustesting
Sponsored by SGS Life Science Services


Best Practices for Effective Environmental Monitoring Program in Bio/Pharmaceutical Production
Available until April 22, 2015
Contamination poses a threat to process and product integrity, as well as patient safety. A comprehensive environmental monitoring program can ensure that manufacturing areas, cleanrooms, production equipment, and water and gas utilities are free of viable and non-viable contamination and meet regulatory requirements. In this webcast, learn about pertinent regulatory and quality standards, as well as best practices for establishing and maintaining an effective environmental monitoring program. Review measures for testing pharmaceutical water systems according to U.S. Pharmacopeial Convention (USP) water monograph as well as procedures to evaluate the purity of production gases.

Register free at www.pharmtech.com/emp
Sponsored by SGS Life Science Services


Increase Control over Quality Management Through Strong Supplier Relationships
Available until April 2, 2015
Understand the regulatory obligations of bio/pharmaceutical companies in a global, outsourced supply chain and challenges with building effective supplier relationships. Learn how a supplier quality management system should provide the ability to aggregate quality metrics in a consistent, measurable, normalized, and repeatable way.

Register free at www.pharmtech.com/relationships
Sponsored by Sparta Systems


Navigating the Analytical Development Challenges for Bioprocess Residuals and Impurities
Available until April 1, 2015
Tracking the clearance of host cell components and process additives residuals is an essential part of process development and characterization of biopharmaceuticals.
In this webinar, learn about challenges presented by residuals, regulatory expectations, analytical approaches for cell- and process-associated residuals, a platform method technology for residuals, and matrix effects.

Register free at www.pharmtech.com/navigating
Sponsored by Eurofins Lancaster Laboratories


Identifying, Analyzing, and Controlling Particles throughout the Biopharmaceutical Product Lifecycle
Available until March 25, 2015
Preformulation screening can identify potential problems and form the basis for long-term stability of biopharmaceutical drug products. One of the main challenges in the development of stable biopharmaceutical products is the control of aggregation and particulate formation. Review how particles can potentially develop through the life cycle of a drug, understand regulatory expectations, and assess analytical techniques available to assess protein aggregation and particulates for innovator drugs and biosimilars.

Register free at www.biopharminternational.com/particles
Sponsored by SGS Life Science Services


For more multimedia content from Biopharm International, including podcasts and videos, click here.